Analysts Forecast 10% Upside For FNDX
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 25 2025
0mins
Should l Buy CNO?
Source: NASDAQ.COM
ETF Analyst Target Prices: The Schwab Fundamental U.S. Large Company Index ETF (FNDX) has an implied analyst target price of $26.73 per unit, indicating a potential upside of 9.74% from its current trading price of $24.36.
Notable Holdings with Upside Potential: Key holdings within FNDX, such as World Kinect Corp, Occidental Petroleum Corp, and CNO Financial Group Inc, show significant upside potential based on analyst targets, with expected increases ranging from approximately 11.94% to 13.76%.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CNO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CNO
Wall Street analysts forecast CNO stock price to rise
3 Analyst Rating
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 45.710
Low
47.00
Averages
48.00
High
50.00
Current: 45.710
Low
47.00
Averages
48.00
High
50.00
About CNO
CNO Financial Group, Inc. is a holding company for a group of insurance companies. It provides life and health insurance, annuities, financial services and workforce benefits solutions through its family of brands, including Bankers Life, Colonial Penn, Optavise and Washington National. It is focused on serving middle-income pre-retiree and retired Americans. It markets its products through the Consumer and Worksite Divisions that reflect the customers served by the Company. The Consumer Division serves individual consumers, engaging with them on the phone, virtually, online, face-to-face with agents, or through a combination of sales channels. The Worksite Division focuses on the sale of voluntary benefit life and health insurance products in the workplace for businesses, associations and other membership groups, interacting with customers at their place of employment and virtually. It also offers a suite of voluntary benefits, benefits administration technology and advocacy services.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Dividend Growth Expectation: CNO Financial Group is expected to announce a dividend increase this May, continuing its 13-year streak of regular growth, with analysts forecasting an annual dividend of approximately $0.71 per share, translating to a quarterly dividend of about $0.177, which represents a 4.1% increase from the current $0.170.
- Historical Dividend Performance: The last dividend paid by CNO Financial was $0.170 per share in March 2026, yielding 1.49%, and the company increased its dividend by 6.25% last April, from $0.1600 to $0.1700, demonstrating its commitment to consistent dividend growth.
- Dividend Growth Rate: Over the past five years, CNO Financial has achieved a dividend growth rate of approximately 2.60%, with a current payout ratio of 10.90%, indicating a balance between returning value to shareholders and reinvesting in business expansion.
- Dividend Quality Ratings: CNO Financial holds a B+ rating for safety, a C rating for growth, a C⁻ rating for yield, and a B rating for consistency in its dividend quality metrics, reflecting the company's stability and sustainability in dividend payments.
See More
- Sustained Sales Growth: CNO Financial Group achieved its 15th consecutive quarter of sales growth in Q1 2026, with total new annualized premiums rising by 11%, demonstrating strong demand in the middle market and a unique agent distribution model that further solidifies its competitive edge.
- Strong Medicare Performance: Total Medicare policies sold increased by 24%, with Medicare Supplement sales soaring by 53%, reflecting a market shift in consumer preferences from Medicare Advantage to Medicare Supplement, thereby enhancing the company's product mix.
- Robust Capital Returns: The company reported operating earnings per share of $1.05 for the quarter, up 33% year-over-year, while returning $77 million to shareholders through share repurchases, showcasing its commitment to shareholder returns and effective capital management.
- Stable Outlook: Despite macroeconomic volatility, CNO affirmed its original guidance for 2026, indicating continued profitability growth, and plans to raise its return on equity (ROE) targets for 2027, reflecting the company's confidence in future performance.
See More
- Earnings Beat: CNO Financial's Q1 non-GAAP EPS of $1.05 exceeded expectations by $0.12, demonstrating robust profitability growth that enhances investor confidence in the company's financial health.
- Revenue Growth: The company reported Q1 revenue of $1.03 billion, a 3.0% year-over-year increase, surpassing market expectations by $30 million, indicating sustained competitive strength in the market.
- Future Outlook: CNO Financial projects an 8% EPS growth for 2026, focusing on momentum in Medicare Supplement plans, which reflects the company's confidence and strategic direction for future growth.
- Market Rating: Seeking Alpha's Quant Rating on CNO Financial shows a positive trend, reflecting analysts' optimistic outlook on the company's future performance, potentially attracting more investor interest.
See More
- Earnings Announcement: CNO Financial is set to announce its Q1 earnings on April 30th after market close, with consensus EPS estimates at $0.93, reflecting a 17.7% year-over-year growth, indicating sustained profitability.
- Revenue Expectations: The revenue estimate for Q1 stands at $1 billion, flat year-over-year, showcasing the company's effective strategy in maintaining stable revenue streams despite market challenges.
- Historical Performance: Over the past year, CNO has beaten EPS estimates 75% of the time and revenue estimates 100% of the time, reflecting the company's reliability in financial forecasting and bolstering market confidence.
- Revision Trends: In the last three months, EPS estimates have seen two upward revisions and revenue estimates one upward revision, indicating analysts' optimistic outlook on CNO's future performance, further enhancing investor confidence.
See More
- Earnings Report Schedule: CNO Financial Group will release its Q1 2026 results after market close on April 30, 2026, providing critical financial performance data that will help analysts assess the company's position in the economic landscape.
- Conference Call Timing: The company will host a conference call on May 1, 2026, at 11:00 a.m. Eastern Time to discuss the earnings results, allowing investors to register for participation and ensuring transparent and timely communication.
- Webcast Participation: For investors preferring online participation, CNO will broadcast the conference call live via its website, enhancing accessibility for investors and improving interaction between the company and its stakeholders.
- Replay Availability: Following the call, a replay will be available on CNO's website, ensuring that investors who could not attend live can still access important information, further enhancing the reach and transparency of the company's communications.
See More
- Rating Affirmation: AM Best has affirmed CNO Financial Group's Financial Strength Rating of A (Excellent) and Long-Term Issuer Credit Ratings of 'a' (Excellent), reflecting its strong balance sheet and stable operating performance.
- Business Growth: CNO has achieved sustained premium growth through a diversified range of income sources, with stable earnings growth across all lines of business further solidifying its market position, demonstrating resilience in a highly competitive market.
- Liquidity Advantage: CNO's liquidity is viewed as a key strength of its balance sheet, with its investment portfolio reliably yielding competitive returns, enhancing the company's financial stability.
- Risk Management Strategy: To address capital strain from rapid new business growth, CNO strategically utilizes reinsurance to transfer risk to its Bermuda subsidiary, CNO Bermuda Re Ltd, thereby optimizing its capital structure.
See More







